Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative Activity

被引:48
作者
Zhao, Huiping [1 ]
Kusuma, Bhaskar Reddy [1 ]
Blagg, Brian S. J. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 07期
关键词
Heat shock protein 90; Hsp90; inhibitors; novobiocin; stucture-activity relationships; breast cancer; PROTEIN-FOLDING MACHINERY; HSP90; INHIBITORS; MOLECULAR CHAPERONE; DNA GYRASE; ANALOGS; CANCER; LIBRARY;
D O I
10.1021/ml100070r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structural modifications to the coumarin core and benzamide side chain of novobiocin have successfully transformed the natural product from a selective DNA gyrase inhibitor into a potent inhibitor of the Hsp90 C-terminus. However, no structure-activity relationship studies have been conducted on the noviose appendage, which represents the rate limiting synthon in the preparation of analogues. Therefore, a series of sugar mimics and nonsugar derivatives were synthesized and evaluated to identify simplified compounds that exhibit Hsp90 inhibition. Evaluation against two breast cancer cell lines demonstrated that replacement of the stereochemical complex noviose with simplified alkyl amines increased antiproliferative activity, resulting in novobiocin analogues that manifest IC50 values in the midnanomolar range.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 29 条
[1]   A non-toxic Hsp90 inhibitor protects neurons from Aβ-induced toxicity [J].
Ansar, Sabah ;
Burlison, Joseph A. ;
Hadden, M. Kyle ;
Yu, Xiao Ming ;
Desino, Kelly E. ;
Bean, Jennifer ;
Neckers, Len ;
Audus, Ken L. ;
Michaelis, Mary L. ;
Blagg, Brian S. J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) :1984-1990
[2]   Hsp90: A novel target for the disruption of multiple signaling cascades [J].
Bishop, Stephanie C. ;
Burlison, Joseph A. ;
Blagg, Brian S. J. .
CURRENT CANCER DRUG TARGETS, 2007, 7 (04) :369-388
[3]   Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation [J].
Blagg, BSJ ;
Kerr, TA .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (03) :310-338
[4]  
Brown E., 1998, Ring Nitrogen and Key Biomolecules: The Biochemistry of N-Heterocycles
[5]   Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines [J].
Burlison, Joseph A. ;
Avila, Christopher ;
Vielhauer, George ;
Lubbers, Donna J. ;
Holzbeierlein, Jeffrey ;
Blagg, Brian S. J. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (06) :2130-2137
[6]   Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery [J].
Burlison, Joseph A. ;
Blagg, Brian S. J. .
ORGANIC LETTERS, 2006, 8 (21) :4855-4858
[7]   Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90 [J].
Burlison, Joseph A. ;
Neckers, Len ;
Smith, Andrew B. ;
Maxwell, Anthony ;
Blagg, Brian S. J. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (48) :15529-15536
[8]   Hsp90 as a target for drug development [J].
Chaudhury, Subhabrata ;
Welch, Timothy R. ;
Blagg, Brian S. J. .
CHEMMEDCHEM, 2006, 1 (12) :1331-+
[9]   Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket [J].
Donnelly, Alison ;
Blagg, Brian S. J. .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (26) :2702-2717
[10]   The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity [J].
Donnelly, Alison C. ;
Mays, Jared R. ;
Burlison, Joseph A. ;
Nelson, John T. ;
Vielhauer, George ;
Holzbeierlein, Jeffrey ;
Blagg, Brian S. J. .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (22) :8901-8920